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Abstract
Co-infecting parasites and pathogens remain a leading challenge for global public health
due to their consequences for individual-level infection risk and disease progression.
However, a clear understanding of the population-level consequences of co-infection is
lacking. Here, we constructed a model that includes three individual-level effects of
co-infection: mortality, fecundity, and transmission. We used the model to investigate
how these individual-level consequences of co-infection scale up to produce
population-level infection patterns. To parameterize this model, we conducted a
four-year cohort study in African buffalo to estimate the individual-level effects of
co-infection with two bacterial pathogens, bovine tuberculosis (BTB) and brucellosis,
across a range of demographic and environmental contexts. At the individual-level, our
empirical results identified BTB as a risk factor for acquiring brucellosis, but we found
no association between brucellosis and the risk of acquiring BTB. Both infections were
associated with reductions in survival and neither infection was associated with
reductions in fecundity. Results of the model reproduce co-infection patterns in the data
and predict opposite impacts of co-infection at individual and population scales:
whereas BTB facilitated brucellosis infection at the individual-level, our model predicts
the presence of brucellosis to have a strong negative impact on BTB at the
population-level. In modeled populations where brucellosis is present, the endemic
prevalence and basic reproduction number (Ro) of BTB were lower than in populations
without brucellosis. Therefore, these results provide a data-driven example of
competition between co-infecting pathogens that occurs when one pathogen facilitates
secondary infections at the individual level.
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Significance Statement
Infection with multiple parasite species is common and the majority of co-infections
involve at least one long-lasting infection. Our data-driven model of chronic co-infection
dynamics shows that accurate prediction at the population-level requires quantifying
both the individual-level transmission and mortality consequences of co-infection. The
infections characterized in this study compete at the population-level. Competition
occurs because one pathogen facilitates both the transmission and progression of the
second pathogen. This mechanism of competition is unique compared to previously
described mechanisms and occurs without of cross-immunity, resource competition
within the host, or a period of convalescence. We recommend assessing the generality of
this mechanism, which could have important consequences for other chronic,
immunosuppressive pathogens such as HIV or TB.
Introduction
Over one sixth of the global human population is estimated to be affected by
co-infection (concurrent infection by multiple pathogens; [1]). Their ubiquity includes
over 270 pathogen taxa and many important chronic infections, such as hepatitis-C,
HIV, TB, and schistosomiasis [1–3]. Mounting evidence suggests that co-infecting
pathogens can interact within the host to influence the individual-level clinical outcomes
of infection [4, 5]. These interactions may also influence the spread of infections at the
population-level [6, 7]. Understanding the effects of co-infection at both levels may,
therefore, be fundamental to the success of integrated treatment and control programs
that target multiple infections [8, 9].
One challenge to predicting the epidemiological consequences of co-infection is that
the mechanisms of parasite interaction — and their resulting changes to susceptibility or
disease progression — occur within the host, while patterns relevant for disease control
occur within a population [10]. Bridging these individual and population scales requires
synthesizing multiple, individual-level processes across natural demographic and
environmental variation. For example, co-infecting pathogens may be one of the best
predictors of individual-level infection risk for a second pathogen [11,12], resulting in
increased or decreased transmission. Co-infecting pathogens may also moderate the
individual-level survival and fecundity costs of infection [4, 13]. Yet, the population-level
consequences of co-infection are influenced by the net effects of these potentially
non-linear individual-level processes [14,15].
At the population-level, theoretical studies have highlighted the range of dynamics
generated by co-infecting pathogens [6, 16,17]. Even for unrelated pathogens,
co-infection can dramatically modify infection dynamics through ecological mechanisms
such as convalescence and disease induced mortality [15,18–21]. This theoretical work
builds on a detailed database of childhood infections, thereby providing a data-driven
understanding of co-infection dynamics for acute, immunizing infections. In contrast,
data and theory on the effects of co-infection with long-lasting infections are limited
(but see, [22]). Chronic co-infections are of particular interest in this context, because
they are responsible for the majority of co-infections [1] and have the potential to
dramatically alter infection patterns [14]. Their protracted presence in the host brings
increased complexity to pathogen interactions, challenging model development and
evaluation. Detailed longitudinal sampling or experimental studies are required to
unravel their precise mechanisms and potentially asymmetric outcomes of
interaction [22]. Few datasets simultaneously estimate the individual-level transmission,
survival, and fecundity consequences of co-infection. To address this gap, we provide a
data-driven investigation of co-infection dynamics for chronic pathogens.
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We focused our research on two chronic bacterial infections, bovine tuberculosis
(BTB) and brucellosis, in a wild population of African buffalo (/textitSyncerus caffer)
to ask, how do the individual-level consequences of co-infection scale up to produce
population-level infection patterns? This system allows us to simultaneously monitor
both individual and population levels of the infection process [4, 7] in a natural reservoir
host [23, 24]. Furthermore, BTB and brucellosis have well-characterized and asymmetric
effects on the within-host environment. BTB is a directly-transmitted, life-long
respiratory infection that dramatically modifies host immunity [25]. African buffalo
infected with BTB have reduced innate immune function and increased inflammatory
responses [4]. Conversely, brucellosis is a persistent infection of the reproductive system.
It persists within phagocytirc cells [26], and infection invokes a less severe immune
response compared to BTB [27]. These differences and our ability to observe the
natural history of both infections make BTB and brucellosis an ideal system to explore
disease dynamics across scales.
Our approach combines a novel mathematical model of the co-infection dynamics of
BTB and brucellosis and a 4-year cohort study of 151 buffalo (Fig 1). For this model,
all parameters describing the consequence of co-infection were estimated from field data;
they include the individual-level consequences of co-infection on mortality, fecundity,
and infection risk. We quantified these parameters by tracking the individual infection
profiles of each buffalo, which were monitored at approximately six-month intervals and
resulted in over 4386 animal-months of observation time from two capture sites. We
show that the model accurately reproduces observed co-infection patterns and use the
model to predict the reciprocal effects of brucellosis and BTB on each other’s dynamics.
In addition, we assess the relative importance of each individual-level process on
co-infection dynamics.
Figure 1. Conceptual diagram of data collection, model, and evaluation. (center)
Schematic representation of the disease model defined in SI Appendix 2. Hosts are
represented as Susceptible (S), infected with TB only (IT ), infected with brucellosis only
(IB), co-infected with both infections (IC), persistently infected with brucellosis only but
no longer infectious (RB), and persistently infected with brucellosis and co-infected with
BTB (RC). (left) A detailed cohort study informs model parameterization, including
the mortality, transmission, and fecundity consequences of co-infection as well as the
(right) transmission parameters for both infections. The prevalence plot illustrates that
the model accurately reproduces the observed co-infection patterns in the data. Bars
represent model results and dots represent the data.
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Results
Individual-level consequences of co-infection: model
parameterization
BTB and brucellosis were associated with additive increases in mortality (Fig 2a; SI
Appendix 1 Table S1). Approximate annual mortality rates in the data were 0.056 (10
mortalities/175.75 animal years) in uninfected buffalo, 0.108 (6 mortalities/55.5 animal
years) in buffalo with BTB alone, 0.144 in buffalo with brucellosis alone (13 mortalities/
90.5 animal years), and 0.21 (9 mortalities/43.8 animal years) in co-infected buffalo.
After accounting for environmental and demographic covariates with a Cox proportional
hazards regression model, BTB was associated with a 2.82 (95% CI 1.43- 5.58) fold
increase in mortality, and infection with brucellosis was associated with a 3.02 (95% CI
1.52-6.01) fold increase in mortality compared to uninfected buffalo. Co-infected buffalo
were associated with an 8.58 (95% CI 3.20-22.71) fold increase in mortality compared to
uninfected buffalo (Fig 2a). Mortality rates were also influenced by buffalo age and
capture site, but the effect of co-infection remained consistent across all ages and in
both sites (SI Appendix 1). Neither infection was associated with reductions in
fecundity (described in detail in SI Appendix 1, Fig S1). Uninfected buffalo were
observed with a calf 68% (11/16) of the time compared to 37% (6/16), 29% (7/24), and
57% (4/7) in BTB positive, brucellosis positive, and co-infected adult buffalo.
The consequences of co-infection on infection risk were asymmetric (Fig 2b; SI
Appendix 1, Table S2). Approximate brucellosis incidence rates were 0.05 (18
infections/340 animal years) in uninfected buffalo compared to 0.08 (8 infections/104
animal years) in buffalo with BTB. Approximate BTB incidence rates were 0.08 (27
infection/ 340 animal years) in uninfected buffalo and 0.07 (9 infections/ 138 animal
years) in buffalo with brucellosis. After accounting for demographic covariates in a Cox
proportional hazards regression model, brucellosis infection risk was 2.09 (95% CI 0.89 –
4.91) times higher in buffalo with BTB compared to susceptible buffalo. BTB infection
risk was similar in uninfected buffalo and buffalo with brucellosis. The effect BTB on
brucellosis infection risk varied by capture-site, with the effect of BTB varying from no
change at one site to a 4.32 (95% CI 1.51 – 12.37) fold increase in risk at the other site
(interaction term for BTB×site: p-value = 0.045; SI Appendix 1, Table S2). Brucellosis
infection risk also varied with buffalo age. Early reproductive-aged buffalo were
associated with increased infection risk. Our model parameterization, therefore,
represents increased brucellosis transmission in early reproductive-aged buffalo and the
average effect of BTB on brucellosis infection risk accross sites. Talbes S3 and S4 in SI
Appendix 2 provides a summary of the consequences of co-infection on brucellosis
transmission, BTB transmission, mortality, and fecundity quantified in our data
analyses.
Population-level consequences of co-infection: basic
reproduction number and prevalence
We built a disease dynamic model to translate the individual-level effects quantified
above into predicted population-level effects of co-infection (Fig 1; SI Appendix 2). We
estimated parameter values for the transmission rate of BTB and brucellosis by
minimizing the sum of squared errors between BTB and brucellosis infection prevalence
in our data and in an age-matched sample from the model. BTB prevalence in the data
was 27% and brucellosis prevalence was 34%. The resulting transmission parameters
(BTB 1.331× 10−3, brucellosis 5.764× 10−1) accurately predict the positive association
between BTB and brucellosis observed in the data (Fig 1) and allow us to predict
equilibrium infection levels and the basic reproduction number in modeled populations
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Figure 2. Parameter estimation: Cox proportional hazards analysis of the cohort study.
(a) Predicted mortality estimates for uninfected, infected, and co-infected adult buffalo.
(b) Predicted estimates and standard error for the proportional increase in infection risk
in buffalo with the second infection compared to susceptible buffalo. Brucellosis infection
risk was 2.09 times higher in animals with BTB compared to susceptible animals but
BTB infection risk was similar in buffalo with and without brucellosis. The dashed line
indicates no change in infection risk.
with and without co-infection. The basic reproduction number, Ro,i (i = T, B for
infection with BTB or brucellosis) is defined as the average number of secondary cases
generated by a single infection in a susceptible population. The presence of brucellosis
infection results in large reductions in Ro,T , with a predicted Ro,T = 3.4 in populations
where brucellosis is absent and Ro,T= 1.5 in populations where brucellosis is present.
The predicted equilibrium BTB prevalence was also lower in populations where both
pathogens occur, with a BTB prevalence of 65.8% in populations where brucellosis is
absent compared to 27.9% when both pathogens co-occur. Conversely, the presence or
absence of BTB has only minor effects on the Ro and equilibrium prevalence of
brucellosis. To represent uncertainty in the individual-level consequences of co-infection,
we used Monte Carlo sampling of the parameters quantified in our statistical analyses
(Fig 2; SI Appendix 2). Figure 3 displays the effect of co-infection when uncertainty in
input parameters is considered. In this range of parameter values (parameter space),
96% of model trajectories predicted a lower BTB prevalence in populations with
co-infection. In the remaining 4%, brucellosis did not persist in populations with or
without co-infection due to high mortality rates and low facilitation rates (Fig S4, SI
Appendix 2).
To generalize these results, we explored the population-level consequence of
co-infection over a range of parameter values (4). By manipulating the transmission and
mortality consequences of co-infection, we explored infection levels in other
environmental contexts where the individual effects of co-infection may be reduced or
exacerbated. The resulting prevalence surfaces suggest that, co-infecting pathogens will
have a negative effect on prevalence if co-infected individuals have elevated mortality
and reduced or similar susceptibility. Co-infecting pathogens are predicted to have a
positive effect if co-infected individuals have increased susceptibility and minimal
changes in mortality. In contrast, BTB and brucellosis are predicted to have drastically
different responses to co-infection for parameter values where co-infection modifies both
processes. BTB prevalence was lower in populations with brucellosis for most parameter
values while the effect of BTB on brucellosis was more variable. This difference is due
to BTB’s long infection duration because the cumulative effect of facilitation increases
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with infection duration.
At the parameter values quantified in our empirical dataset, these results illustrate
that the lower BTB prevalence in populations where brucellosis co-occurs is driven two
mechanisms: (1) BTB increases the transmission rate of brucellosis but not vice versa
and (2) co-infection results in increased mortality. As a result, at the individual-level,
buffalo infected with BTB are more likely to become infected with brucellosis and die
than their uninfected counterparts. The resulting reductions in infection duration mean
that the prevalence of brucellosis is predicted to reduce BTB infection-levels at the
population-level. These results are robust to several important changes in the model
structure, including alternative forms of density dependence and a range of model
parameters (see sensitivity analyses in SI Appendix 2). Model dynamics in all
formulations are qualitatively similar, although there is some variation in overall
magnitude of change with co-infection.
Figure 3. Model predictions: reciprocal consequences of co-infection for the basic
reproduction number (Ro) and endemic prevalence. (a) The estimated Ro for BTB was
lower in populations where brucellosis co-occurs while the estimated Ro for brucellosis
was similar in populations with and without BTB. (b) The estimated endemic prevalence
of BTB was lower in populations where brucellosis co-occurs while the estimated endemic
prevalence of brucellosis was similar in populations with and without BTB. Uncertainty
was incorporated into model predictions using Monte Carlo sampling of parameters
describing the individual-level consequences of co-infection (SI Appendix 3). Dots and
lines represent the mean and standard error of model predictions. (c) Histograms of
the difference in Ro and (d) endemic prevalence show the negative consequence of
co-infection for BTB and neutral consequences of co-infection for brucellosis at the
population-level. Change is calculated for each parameter combination as the predicted
value in populations with co-infection subtracted by the predicted value in populations
with a single pathogen. Purple bars and lines represent BTB; green lines represent
brucellosis.
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Figure 4. The difference between predicted prevalence values in populations with and
without co-infection for BTB prevalence (left panel) and brucellosis prevalence (right
panel). Reds indicate that infection with the second pathogen increased in the presence
of the focal pathogen; blues indicate that infection with the second pathogen decreased
in the presence of the focal pathogen; yellows indicate no change. Contour lines indicate
changes in prevalence by 20%. Stars and error bars indicate mean and standard error
parameter values estimated in the data. Proportional increases in mortality are measured
as the increase compared to the rate in susceptible individuals. Proportional increases
in transmission represent the increase in the transmission rate for the focal pathogen in
the presence of the co-infecting pathogen.
Discussion
Our study provides a mechanistic understanding of how chronic co-infections mediate
each other’s dynamics. Model dynamics show that co-infection can increase or decrease
the prevalence of a second pathogen depending on the net effect of co-infection on
transmission and infection duration, via mortality. When co-infection modifies only
transmission or only mortality, the prevalence of the second pathogen predictively
increases or decreases. Previous work has quantified the disease dynamic consequences
of changes in transmission through a range of mechanisms: cross immunity,
antibody-mediated enhancement, immunosuppression, and convalescence [16,20,28,29].
Here, we show that transmission and mortality should be considered concurrently,
following theoretical predictions [14,22,30]. When a co-infecting pathogen modifies both
processes, non-linear responses mediated through the co-infecting pathogen can have a
large impact on population-level disease dynamics.
By exploring the co-infection dynamics of BTB and brucellosis, we also provide a
data-driven example of competition between pathogens in a natural population. Here,
the mechanism driving competition is different from previously described examples that
focus on cross-immunity [29], resource competition within the host [31], or ecological
competition by convalescence [20,21]. Specifically, the mechanism of parasite interaction
in these examples occurs when one infection reduces the transmission of the second
pathogen, typically by removing individuals from the susceptible pool during
co-infection. By contrast, BTB facilitates the transmission of brucellosis at the
individual-scale (Fig 2). Because co-infection is associated with elevated mortality,
co-infected individuals are also removed from the population at a faster rate.
Competition, therefore, occurs at the population-level: BTB is predicted to have a lower
prevalence and lower Ro,T in populations where brucellosis occurs compared to
populations without brucellosis.
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The model structure presented in this study was informed by our empirical data. As
a result, it incorporates realistic age-specific transmission and mortality rates as well as
data-driven estimates of the consequences of co-infection. However, additional detail
could be added to our model. Specifically, we do not know the consequences of
co-infection on recovery or infectiousness, two processes likely to influence persistent
infections [18,22]. We also do not consider genetic variation within our buffalo
population that may mediate susceptibility to both pathogens. However, our model’s
ability to re-create co-infection patterns with the mechanisms characterized is
encouraging. Furthermore, our empirical results account for natural variation in
demographic and environmental conditions and model-predictions including this
variation remain informative. Thus, our results suggest the importance of co-infection in
generating population-level association patterns relative to environmental or genetic
drivers of infection.
Given the ubiquity and documented individual-level impacts of chronic co-infections
on the host, these results illuminate two core challenges in the design and application of
integrated control strategies. First, it remains unclear how commonly competition
between co-infecting pathogens is occurring. Understanding which pathogens may be
competing in co-infected host populations is crucial to estimating the costs and benefits
of disease control interventions. For example, in the presence of pathogen competition,
removing one pathogen may unintentionally lead to a resurgence of or increases in
prevalence of a competing pathogen. Our results suggest that competition at the
population-level can occur between unrelated pathogens and in the absence of
competition for shared resources within the host. Competition appears to be strongest
when pathogens have asymmetric effects on transmission. Similar asymmetries in
transmission occur in HIV-malaria [6] and HIV-HCV co-infections [32], suggesting a role
for this mechanism in other systems. Second, knowledge on which chronic pathogens are
most likely to be influenced by co-infection remains largely theoretical (excluding
notable progress with HIV- co-infection [6, 22]). Here, the immunosuppressive pathogen,
BTB [4,33], was strongly influenced by co-infection at the population-level, and our
analyses show that BTB prevalence should typically decline in the presence of another
chronic pathogen, provided that co-infected hosts suffer greater mortality. This raises
the question of whether there are traits of chronic pathogens (e.g. immunosuppressive
effects) that make them more likely to be influenced by co-infection. Studies addressing
these questions are urgently needed to target both research and treatment on the
pathogens most likely to be influenced by co-infection. Such a research agenda will
require additional synthesis of theoretical and empirical work: theoretical studies are
needed to characterize how population-level infection dynamics will response to changes
in transmission and mortality for different types of pathogens and empirical studies are
needed to quantify when and how these parameters change through pathogen
interactions. In combination, this work can provide clarity about the consequences of
co-infections, and their control, at both the individual and population scales.
Materials and Methods
Model Development
We developed an age-structured continuous time disease dynamic model to explore the
consequences of co-infection on BTB and brucellosis infection (Fig 1). Animals are
represented with six groups: susceptible to both infections (S), infected with BTB only
(IT), infected with brucellosis and infectious (IB), co-infected with both pathogens (IC),
persistently infected with brucellosis but no longer infectious (RB), or persistently
infected with brucellosis and co-infected with BTB (RC). We modeled BTB as a lifelong
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infection with density dependent transmission [34]. Transmission of brucellosis was
assumed to be frequency dependent because transmission occurs through ingestion of
the bacteria shed in association with aborted fetuses, reproductive tissues, or discharges
during birthing [35]. We did not consider vertical transmission because serological
evidence suggests that it is rare in African buffalo [36] and experimental evidence for
vertical transmission varies by host species (cattle [37], bison [38], elk [39]). Buffalo
populations experience density dependent recruitment [40], represented with a
generalized Beverton and Holt equation [41]. This 2 parameter representation of density
dependence gives a stable age structure and relatively constant population size ( [42]; SI
Appendix 2, Fig S3). A full description of the model is provided in SI Appendix 2.
The individual-level consequences of co-infection can be summarized by 4
individual-level processes: (1) the effects of prior infection with brucellosis on the rate of
acquiring BTB infection (2) the effects of prior infection with BTB on the rate of
acquiring brucellosis infection, (3) the effects of co-infection on mortality rate, and (4)
the effects of co-infection on birth rates. To investigate the consequences of these four
individual level processes on disease dynamics, we quantified the mean values of these
rates in susceptible, singly infected, and co-infected buffalo. Transmission rates,
mortality rates, and the proportional reductions in fecundity with infection may be age
dependent, but recovery and recrudescence are assumed to be independent of age.
Individual-level data and parameter estimation
We conducted a longitudinal study of 151 female buffalo to estimate the consequences of
BTB and brucellosis infection. Buffalo were captured at two locations in the
south-eastern section of KNP, radio collared for re-identification, and re-captured
biannually at approximately 6 month intervals until June-October of 2012. During each
capture, we recorded brucellosis infection status, BTB infection status, age, and the
animals’ reproductive status. Brucellosis testing was conducted with an ELISA
antibody test and BTB testing was conducted with a gamma-interferon assay [43,44].
Detailed methodological descriptions of our capture and disease testing protocols are
provided in SI Appendix 3.
We assessed the effects of co-infection on mean mortality rates and the mean rate
animals acquired infection by analyzing our longitudinal time-to-even data using
semi-parametric Cox models where an individual’s covariates representing infection
change over time. Specifically, we fit three regression models to predict three events:
the time-to-mortality in uninfected, BTB+, Brucellosis +, and co-infected individuals;
the time-to-infection with brucellosis in buffalo with and without BTB; and the
time-to-infection with BTB in buffalo with and without brucellosis. In all analyses, we
include age and initial capture site as time-independent, categorical variables and
infection status as a time-dependent explanatory variable. We also evaluate whether the
association between brucellosis and BTB varied by age or site by including interactions
terms between BTB and each environmental variable. The supplemental information
includes a detailed quantification of our re-capture rates, justifies the use of the Cox
model, and outlines our model selection procedure.
Model evaluation and inference
Parameter values for the transmission rate of BTB and brucellosis were estimated by
fitting the model to prevalence estimates in the study population. Our data do not
represent a random sample because buffalo aged over the course of the study, with a
median age of 3.4 years in buffalo initially captured in June-October 2008. We,
therefore, calculate prevalence after randomly sampling one time point for each
individual. We estimate prevalence in the study population as the mean prevalence in
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1000 replicate samples. Model estimates of prevalence were calculated numerically using
the deSolve package [45]. The transmission rates of both pathogens were estimated by
numerically minimizing the sum-of-squared errors between the mean prevalence
estimates for BTB and brucellosis and an age-matched estimate of prevalence from the
model. We used the Nelder-Mead algorithm implemented with the optim function in R
to minimized this function. We evaluated our model by comparing its ability to recreate
co-infection patterns in the data (Fig 1). We calculated Ro numerically using the next
generation method [46], reviewed in [47]. We calculated endemic infection levels of both
pathogens in populations with and without the co-infecting pathogen.
Supporting Information
Extended methods are provided in the SI Appendix.
Appendix 1: Additional information statistical analysis
Appendix 2: Additional information on model development and analysis
Appendix 3: Additional information on field methods and diagnostic testing
Acknowledgments
We thank South African National Parks (SANParks) for their permission to conduct
this study in Kruger. We thank P. Buss, M. Hofmeyr and the entire SANPark’s
Veterinary Wildlife Services Department for animal capture and logistical support. We
thank the Webb lab group for comments on the manuscript and technical support.
Animal protocols for this study were approved by the University of Georgia (UGA) and
Oregon State University (OSU) Institutional Animal Care and Use Committees (UGA
AUP A2010 10-190-Y3-A5; OSU AUP 3822 and 4325). This study was supported by a
National Science Foundation Ecology of Infectious Diseases Grant to A. Jolles and V.
Ezenwa (EF-0723918/DEB-1102493, EF-0723928) and a NSF-GRFP and NSF-DDIG
award to E. Gorsich (DEB-121094).
10/30
Supporting Information:
Interactions between chronic diseases: asymmetric
outcomes of co-infection at individual and population
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Appendix 1. Additional information on statistical
analyses
Mortality
Our mortality dataset included 127 individuals and 38 mortality events. We
estimated the time of mortality as midway between the last capture period the animal
was observed and the subsequent capture period (6 months later) when it was recovered
unless the exact mortality date was known. This assumption is supported by our
sampling design that recovered most animals quickly after death. For 20 of the
mortality events included here, we were able to estimate the mortality date within one
month of error by comparing the date the animal was last observed with the date it was
known to be dead. Animals were identified as dead by either finding the carcass or
recovering the radio-collar. All radio-collars were recovered before the subsequent
capture period. The high recapture rates in this study made the Cox proportional
hazards model an acceptable representation of the time-to-event process [48]. We
evaluated the proportional hazards assumption of the model using Schoenfeld
residuals [49,50] quantified with the cox.zph function in the survival package [51]. To
test for differences in the distribution of mortality times in uninfected and infected
buffalo, we included the presence or absence of brucellosis-positive test result (bruci)
and a BTB-positive test result (BTBi) as time-dependent explanatory variables. We
also account for the buffalo’s age at first capture (agecati) and capture location (sitei)
as time-independent, categorical variables. These main effects and interaction terms
give the following full model:
hi(t) ∼ h0(t)exp(β1BTBi + β2bruci + β3,jagecati + β4sitei+
β5BTBi ∗ bruci + β6,jBTBi ∗ agecati + β7,jbruci ∗ agecati+
β8BTBi ∗ sitei + β9bruci ∗ sitei)
where hi(t) represents the hazard function for the i th individual and describes the
instantaneous risk of mortality at time, t, conditional on survival to that time. The
baseline hazard is represented by ho(t) and remains unspecified.
We conducted model selection in two stages. First, we considered the relationship
between the buffalo’s age at first capture and mortality rate by only considering age as
a predictor of mortality. This is because both infections are assumed to be life-long, so
we were concerned that the positive association between age and testing positive for
both infections could bias our results. We considered 4 potential representations of age
as an explanatory variable (age1: late development with a sub-adult category, 1-2.9,
3-5.9, 6+; age2: late development without a sub-adult category, 1-2.9, 3+; age3: early
development with a sub-adult category, 1-1.9, 2-4.9, 5+; age4: early development
without a sub-adult category, 1-1.9, 2+). The age categories representing late
development (age1: 1-2.9, 3-5.9, 6+, age2: 1-2.9, 3+) provided better fits based on AIC
(Akaike information criterion) compared to the age categories representing early
development with the same number of parameters (age3: 1-1.9, 2-4.9, 5+, age4: 1-1.9,
2+). The addition of an extra age category had a minimal effect on model fit. The AIC
values for each model were, 330.9, 329.9, 336.6, and 335.8, for models including age1,
age2, age3, and age4, respectively. Second, we conducted a formal model selection
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following the full model in equation 1 with age2 representing the covariate for age. We
used backwards selection by sequentially removing interaction terms and then main
effects terms based on drop-in-deviance χ2 tests. From the final model, we evaluate β1
to determine the mortality consequences of BTB, β2 to determine the mortality
consequences of brucellosis, and β5 to determine if buffalo co-infected with both
pathogens have exacerbated mortality.
We converted these parameters into infection-specific mortality rates by interpreting
the exponentiated model coefficients as having a multiplicative effect on the mortality
hazard (e.g. the mortality rate in buffalo with BTB is equal to the mortality rate in
susceptible buffalo multiplied by exp(β1)).
Table S1. Parameter values (β), standard errors (SE), and significance tests (Z-
value, p-values) for each covariate in the final model. A positive parameter value for
BTB or brucellosis indicates an increased mortality hazard by a factor of exp(β). A
positive parameter for site indicates higher mortality in the Crocodile Bridge capture
site compared to Lower Sabie. A positive parameter for age indicates higher mortality
in juveniles (age < 3) compared to adults (age ≥ 3). The data contained 127 animals
and 38 mortality events.
Parameter Estimate (β) SE Z-value p-value
BTB (β1) 1.04 0.35 2.98 0.003
bruc (β2) 1.11 0.35 3.16 0.002
age (β3) 1.18 0.33 3.35 ¡ 0.001
site (β4) 0.74 0.32 2.27 0.023
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Fecundity
We assessed the effects of infection and co-infection on fecundity by testing for an
association between infection status and reproductive status, defined as having a calf.
Birthing in African buffalo occurs seasonally, with most births occurring from December
to March (5). Buffalo calves are often weaned approximately 5-6 months later [52]. We,
therefore, expected calf observations to be less accurate just before or during birthing
season and account for this by only including captures immediately following the
birthing season (March to July). Calving is strongly age-dependent and only buffalo 4
years of age or older were considered in this analysis, following previous analyses of
buffalo fecundity [36]. The resulting dataset includes 143 observations from 62 buffalo
over the course of our longitudinal study. Of the 143 observations, 29% were observed
with a calf at heel. Uninfected adult buffalo (age ≥ 5) were observed with a calf at heel
68% (11/16) of the time, buffalo with BTB were observed with a calf at heel 37% (6/16)
of the time, buffalo with brucellosis were observed with a calf at heel 29% (7/24) of the
time, and co-infected adults were observed with a calf at heel 57% (4/7) of the time.
We tested if reproductive status is associated with infection status with a generalized
linear mixed model with binomial errors and a logit link function for the response. We
considered all main effects and interactions specified for previous analyses as dependent
variables: BTB infection, brucellosis infection, age, capture site and interactions
between BTB-brucellosis, BTB-age, BTB-site, brucellosis-age, and brucellosis-site.
Animals were sampled over time, so we accounted for animal ID as a random effect.
We conducted model selection on the fixed effects in two stages. First, we considered
the relationship between the buffalo’s age and fecundity by only considering age as a
predictor. In this analysis, the age categories representing early development (age3 =
1-1.9, 2-4.9, 5+, AIC = 166.5) provided better fits compared to age categories
representing late development (age1 = 1-2.9, 3-5.9, 6+, AIC = 168.5). Second, we
conducted a formal model selection following the full model with age3 representing the
covariate for age. Model selection was conducted by sequentially removing interaction
terms and then main effects terms based on drop-in-deviance χ2 tests. After model
selection, only age was a significant predictor of fecundity (Z = 3.30, p-value = 0.001).
The odds of a buffalo being observed with a calf were 3.84- fold (95% CI 1.73- 8.54)
higher in adult buffalo aged over 5 years old compared to sub-adult buffalo aged less
than 5 years.
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Fig S1. Proportion of buffalo observed with a calf. Proportion estimates and standard
errors are based on the number of observations with a calf in the data.
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Infection risk
Our dataset for brucellosis incidence included 26 brucellosis incidence events in the 110
buffalo who were sero-negative at their first capture (Fig S2). Our dataset for BTB
incidence included 36 BTB incidence events in 131 buffalo. We used Cox proportional
hazards models to test for differences in the distribution of infection times in uninfected
buffalo and buffalo that tested positive for the second infection. Using the same
co-variates and model selection procedure described in Table S1, we fit the following full
model,
hi(t) ∼ h0(t)exp(β1infectioni + β2,jagecati + β3sitei
+β4,jinfectioniagecati + β5infectionisitei
where hi(t) represents the hazard function for the ith individual and describes the
instantaneous risk of infection at time, t, conditional on the individual not becoming
infected until that time. For models predicting brucellosis infection risk, we evaluate β1
to estimate the consequences of BTB infection on brucellosis infection risk, β4 to
determine if the consequences of BTB vary across age groups, and β5 to determine if
the consequences of BTB vary between sites. Similarly, for models predicting BTB
infection risk, we evaluate β1 to estimate the consequences of brucellosis infection on
BTB infection risk, β4 to determine if the consequences of brucellosis vary across age
groups, and β5 to determine if the consequences of brucellosis vary between sites.
For both infections, the age categories representing late development (age1 = 1-2.9,
3-5.9, 6+, age2 = 1-2.9, 3+) provided better fits compared to the age categories
representing early development with the same number of parameters (age3 = 1-1.9,
2-4.9, 5+, age4 = 1-1.9, 2+). However, we were unable to consider age1 as a co-variate
because none of the 8 buffalo aged 6 years or older at the initial capture became
infected with brucellosis. AIC values for were 248.03, 250.04, and 251.63 for models
predicting brucellosis infection with age2, age3, and age4 included as a predictor,
respectively. AIC values were 347.80, 349.37, and 349.26 for models predicting BTB
infection with age2, age3 and age4 included as a predictor. Thus, we conducted a formal
model selection for brucellosis and BTB incidence following the full model with age2
representing the covariate for age.
We note that the effect of BTB infection on brucellosis incidence varied by capture
site (β5, BTB:site). Buffalo infected with BTB were associated with a 4.32 (95%CI
1.51-12.37) times higher rate of brucellosis infection at the Lower Sabie site while
buffalo infected with BTB at the Crocodile Bridge site had similar incidence rates
compared uninfected buffalo (Z = - 0.821, p-value = 0.412). The parameters for our
disease model are based on the effect of BTB taken across both sites: buffalo infected
with BTB faced a 2.09 (95% CI 0.89-4.91) fold higher risk of acquiring brucellosis (Z =
1.742, p-value = 0.081).
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Table S2. Parameter values, standard errors, and significance tests (Z-value, p-values)
are shown for each covariate in the final model. A positive parameter value for BTB
or brucellosis indicates an increased mortality hazard by a factor of exp(β). A positive
parameter for site indicates higher infection risk in Crocodile Bridge capture site compared
to Lower Sabie. A positive parameter for age indicates a higher infection risk in juveniles
(age < 3) compared to adults (age ≥ 3).
Parameter Estimate (β) SE Z-value p-value
Brucellosis incidence
BTB (β1) 1.46 0.54 2.73 0.006
age (β2) 1.89 0.43 2.06 0.039
site (β3) 0.71 0.51 1.41 0.158
BTB:site (β5) -2.40 1.20 -2.01 0.045
BTB incidence
age (β2) -0.61 0.37 -1.65 0.10
site (β3) -0.70 0.35 -2.02 0.04
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Fig S2. The number of new BTB and brucellosis infections over the course of the study
in buffalo initially captured in the Lower Sabie and Crocodile Bridge sites show that
infections occurred continuously over the study period.
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Appendix 2. Additional information on model
development and analysis
We developed an age-structured continuous time disease dynamic model of BTB and
brucellosis co-infection. Animals are represented with six groups: susceptible to both
infections, S(t, a); infected with BTB only, IT (t, a); infected with brucellosis and
infectious, IB(t, a); co-infected with both pathogens, IC(t, a); persistently infected with
brucellosis but no longer infectious, RB(t, a); or persistently infected with brucellosis
and co-infected with BTB, RC(t, a). We use this model to calculate the basic
reproduction number, Ro, and project the endemic of numbers of infected and
co-infected individuals. To evaluate the consequences of co-infection for infection
dynamics, we compare Ro and endemic prevalence in modeled populations with one or
both infections. To explore how the individual-level consequences of co-infection
influence co-infection dynamics, we explore the following individual-level processes in a
sensitivity analysis: (1) the effects of prior infection with brucellosis on the rate of
acquiring BTB infection, (2) the effects of prior infection with BTB on the rate of
acquiring brucellosis infection, (3) the effects of co-infection on mortality rate, and (4)
the effects of co-infection on birth rates. Our model parameterization was informed by
our data analysis (Table S3.1). As a result, it incorporates realistic age-specific
transmission and mortality rates as well as data-driven estimates of the consequences of
co-infection. Furthermore, we incorporates uncertainty in the individual-level
consequences of co-infection by conducting 1000 simulations, with parameter values
drawn from the distributions defined in our data analysis (Table S3).
Model simulations and analyses were conducted in R and are publicly available [53].
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Model Structure
We modeled BTB infection as a directly transmitted, lifelong infection, with density
dependent transmission [34]. Transmission of brucellosis was assumed to be frequency
dependent because transmission occurs through ingestion of the bacteria shed in
association with an aborted fetuses, reproductive tissues, or discharges during birthing
(cattle: [35]; bison: [54, 55]). Vertical transmission of brucellosis has been experimentally
demonstrated in cattle and bison (Bison bison) [37, 38], but appears to play a relatively
minimal role in transmission [56]. In other species, such as Elk, vertical transmission
has not been experimentally demonstrated [39]. We did not consider vertical
transmission because serological evidence suggests that it is also rare in African
buffalo [36]. Following sero-conversion, buffalo remain infected and infectious with
brucellosis for two years, following the time course of infection in cattle and
bison [54,56,57]. Upon recovery from active infection, buffalo are assumed to be no
longer infectious. Although persistent infections are possible, recrudescence is rare [56].
Our model incorporates age-structure to represent three features of our data analysis.
First, juvenile buffalo suffer 3.25-fold higher mortality rates compared to adult buffalo
(SI Appendix 1, Table S1). Second, the rate at which buffalo acquired brucellosis was
2.42-fold higher in early reproductive buffalo compared to adult buffalo (SI Appendix 1,
Table S2). Third, only reproductive-aged buffalo were observed with a calf (SI
Appendix 1, Fig S1). We represent there processes by incorporating age-specific
parameters. Table S3 defines the parameters and variables used in the model and Table
S4 defines the values and ranges used.
We assume births, deaths, and the infection process occur continuously. We represent
density dependent recruitment into the first age category [40] with a generalized
Beverton and Holt equation [41]. This form of density dependence is defined with two
parameters. The abruptness parameter, φ, defines the rate at which density dependence
sets in around a characteristic density, defined by the scaling parameter, K. It results in
a realistic stable age structure and relatively constant population size (Fig S3).
The per capita birth rate has the form,
R(a,N(t)) = b(a)
1 + N(t)K
φ
(1)
where b(a) is the per capita age-specific birth rate at low densities and N(t) is the
total population size. We did not find evidence of disease-induced reductions in
fecundity (SI Appendix 1, Fig S1), such that the number of births into an age class is
defined by,
r(a,N(t)) =
{∫∞
0 R(α,N(t))N(α, t)dα if a = 1.
0 otherwise
(2)
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Fig S3. (left) The per-capita birth rate decreases with increasing population size.
Increasing the abruptness parameter, φ, results in stronger density dependence around,
K (red line). (right) The stable age distribution in the absence of infections appears
visually similar to field estimates [58,59].
Table S3. Notation used for model variables and parameters.
Symbol Definition
Variables
S(t, a) buffalo susceptible to both infections of age a at time t
IT (t, a) buffalo infected with BTB only of age a at time t
IB(t, a) buffalo infected with brucellosis only and infectious of age a at time t
IC(t, a) buffalo co-infected with both pathogens of age a at time t
RB(t, a) buffalo persistently infected with brucellosis but no longer infectious of age a at time t
RC(t, a) buffalo persistently infected with brucellosis and co-infected with BTB of age a at time t
Parameters
b(a) age-specific maximum birth rate at low population size
K scaling parameter defining the characteristic population size
φ abruptness parameter controlling the strength of density dependence around K
µS(a) age-specific mortality rate for susceptible buffalo
µT (a) age-specific mortality rate for buffalo with BTB only
µB(a) age-specific mortality rate for buffalo with brucellosis
µC age-specific mortality rate for buffalo co-infected with both pathogens
βT transmission rate for BTB in susceptible buffalo
βB(a) transmission rate for brucellosis in susceptible buffalo
β
′
T transmission rate for BTB in buffalo with brucellosis
β
′
B transmission rate for brucellosis in buffalo with bTB
γ recovery rate for brucellosis
 recrudescence rate for brucellosis
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Table S4. Parameter values, dimensions, and references.
Parameter Value Dimensions Reference
b(a) 0.5 if a ≥ 5, 0 otherwise yr−1 -
K 433 indiv [42]
φ 4 dimensionless [42]
µS(a) 0.06 if 2 < a ≤ 16, 0.1 otherwise yr−1 [42, 60]
µT (a) 2.82µS(a) yr−1 Table S1
µB(a) 3.02µS(a) yr−1 Table S1
µC 8.58µS(a) yr−1 Table S1
βT 1.331 ∗ 10−4 indiv−1day−1 fit
βB(a) 0.576 if a ≥ 5, 0.576exp(0.885) otherwise day−1 fit, Table S2
β
′
T βT indiv
−1day−1 Table S2
β
′
B 2.09βB(a) day−1 Table S2
γ 0.5 day−1 [54]
 0.3 day−1 [56, 57,61]
These assumptions give the following system of partial differential equations,
{ ∂
∂t
+ ∂
∂a
}
S(t, a) = r(a,N(t))− (λT (t) + λB(t, a) + µS(a))S(t, a){ ∂
∂t
+ ∂
∂a
}
IT (t, a) = λT (t)S(t, a)− (λ′B(t, a)− µT (a))IT (t, a){ ∂
∂t
+ ∂
∂a
}
IB(t, a) = λB(t, a)S(t, a)− (λ′T (t) + γ + µB(a))IB(t, a) + RB(t, a){ ∂
∂t
+ ∂
∂a
}
IC(t, a) = λ′T (t)IB(t, a) + λ′B(t, a)IT (t, a) + RC(t, a)− (γ + µC(a))IC(t, a){ ∂
∂t
+ ∂
∂a
}
RB(t, a) = γIB(t, a)− (+ µB(a))RB(t, a){ ∂
∂t
+ ∂
∂a
}
RC(t, a) = λ′TRB(t, a) + γIC(t, a)− (+ µC(a))RC(t, a)
with force of infection,
λT (t) = βT
∫ ∞
0
(It(t, α) + IC(t, α) +RC(t, α))dα
λ′T (t) = β′T
∫ ∞
0
(It(t, α) + IC(t, α) +RC(t, α))dα
λB(t, a) = βB(a)
∫ ∞
0
(IB(t, α) + IC(t, α))dα
λ′B(t, a) = β′B(a)
∫ ∞
0
(IB(t, α) + IC(t, α))dα
We used this model to investigate the consequences of co-infection for Ro and
endemic infection prevalence. We evaluated the consequences of co-infection by
comparing infection levels in scenarios where both diseases were present to scenarios
with a single infection. We calculated endemic infection levels numerically using the
method-of-lines with the ode.1D function in the deSolve package in R [45]. We
calculated Ro numerically using the next generation method [46], reviewed in [47].
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Model sensitivity and uncertainty analysis
We used Monte Carlo simulation to incorporate uncertainty in the individual-level
consequences of co-infection quantified in our data analyses. Parameter estimates from
Cox proportional hazards models are normally distributed with means and standard
errors provided in tables S1 and S2. We drew 1000 random parameter values following
the sampling distributions in table S5. For each value, we quantified of Ro and endemic
prevalence for both pathogens in populations with and without co-infection. Parameter
values were drawn independently (Fig S4). Because of this, some parameters with high
brucellosis mortality and low facilitation with co-infection resulted in low values of
brucellosis prevalence in scenarios with and without co-infection (Fig. 3). This
parameter space occurred 4% of the time, resulting in a heavy density around no change
in brucellosis prevalence with co-infection. BTB prevalence remained above 1% for all
parameters.
Table S5. Parameter values and distributions for the individual-level consequences of
co-infection.
Parameter Calculation Sampling distribution
Mortality in BTB+ buffalo (µT ) µT (a) = µS(a) ∗ exp(ρ1) ρ1 ∼ N (µ = 1.04, σ = 0.35)
Mortality in brucellosis+ buffalo (µB) µB(a) = µS(a) ∗ exp(ρ2) ρ2 ∼ N (µ = 1.11, σ = 0.35)
Mortality in co-infected buffalo (µC) µC(a) = µS(a) ∗ exp(ρ1 + ρ2) -
Increase in brucellosis transmission β′B = exp(ρ3) ∗ βB ρ3 ∼ N (µ = 1.46, σ = 0.41)
Fig S4. Parameter values in Table S5 were drawn independently. Blue values reflect
parameters resulting in a brucellosis prevalence of 0.1% or less for scenarios with and
without co-infection.
We evaluated the sensitivity of our model to changes in the functional form of
density dependence (Fig S5) and in parameter values (Fig S6, Fig S7). We used Latin
Hypercube Sampling and partial rank correlation coefficients (PRCC) to quantify the
strength of linear associations between model output and each parameter [62]. Dots and
error bars represent the partial rank correlation coefficients and 95% confidence intervals
based on 100 samples. Parameter ranges were drawn from a uniform distribution with
ranges from 2 times greater than or less than the base values presented in Table S4.
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Fig S5. Model results using alternative representations of density dependence, including
logistic and Ricker representations. (a) Brucellosis prevalence in buffalo populations
with and without co-infection. (b) BTB prevalence in buffalo populations with and
without co-infection. All three models result in similar qualitative patterns of infection
and co-infection. Under the logistic and Ricker forms of density dependence, the per
capita birth rate has the form, R(a,N) = b(a)(1 − NKL ) and R(a,N) = b(a)exp(−NKR ),
respectively (15). We set the parameter, K, such that all models produced the same
population size in the absence of infection (609 individuals; KL = 1520.4 for logistic;
KR = 419.8 for Ricker).
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Fig S6. Partial rank correlation coefficients and 95% confidence intervals for Ro. Colors
represent the effect of a given parameter on the Ro for BTB (black) or brucellosis (gray).
Confidence intervals account for the 13 multiple comparisons considered here using a
Bonferroni correction.
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Fig S7. Partial rank correlation coefficients and 95% confidence intervals for endemic
prevalence. Colors represent the effect of a given parameter on the prevalence of BTB
(black) or brucellosis (gray). Confidence intervals account for the 13 multiple comparisons
considered here using a Bonferroni correction.
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Appendix 3. Additional information on field methods
and diagnostic testing
Detailed capture information, including chemical immobilization methods and
recapture rates have been described previously [4, 7, 36]. We collected all field data
Kruger National Park (KNP), South Africa. Data collection methods for the results
presented in this work are summarized briefly here.
Buffalo cohort study
We conducted a longitudinal study of 151 female buffalo to estimate the consequences of
BTB and brucellosis infection. An initial 104 female buffalo were captured between
June 2008 and October 2008. Buffalo were captured at two locations in the
southeastern section of KNP. Fifty-three buffalo were captured in the Lower Sabie
region; fifty-one were captured in the Crocodile Bridge region (Fig S8). Buffalo were
radio-collared for re-identification and captured biannually at approximately 6 month
intervals from their initial capture in 2008 until August of 2012. As natural mortalities
occurred throughout the study period, new buffalo were captured and monitored, so
that 47 buffalo were added throughout the course of the study.
During each capture, we recorded brucellosis infection status, BTB infection status,
age, and the animals’ reproductive status. Buffalo age was assessed by tooth eruption in
younger buffalo and by incisor wear in older buffalo [58]. Reproductive status was
quantified by whether the buffalo had a calf (defined as animals < 1 year old) at the
capture immediately following the birthing season (March - July; [36]). For each
capture, we used a combination of visual siting and lactation status to identify buffalo
with calves. Buffalo calves often associate with their mother until the next breeding
season and were distinguishable from other calves by being within a few meters from
the female. In 6% (13/ 204) of observations, calf status was marked as unknown when a
calf was observed but it was not clear who was the mother. In these cases, the focal
animal was identified as having a calf only if they were lactating.
Disease testing
Blood was collected by jugular venipuncture into lithium heparinized tubes for BTB
diagnostics and into tubes with no additives for brucellosis diagnostics. Diagnosis of
brucellosis was based an ELISA test (Brucellosis Serum Ab ELISA test, IDEXX). The
brucellosis ELISA detects the presence of antibodies in serum and has an estimated
sensitivity of 93% and specificity of 87% in African buffalo [43]. Diagnosis of BTB
infection was determined based on a whole blood gamma interferon ELISA assay
(BOVIGAM ELISA kit, Prionics; [44]). The BOVIGAM assay for BTB identifies an
infected animal based on the in vitro production of IFN-gamma by whole blood after
stimulation with Mycobacterium bovis antigen (bovine tuberculin). Diagnosis of BTB is
complicated by non-specific reactivity to environmental mycobacteria, including
Mycobacterium avium antigens. Therefore, we followed an established protocol that
accounts for exposure to M. avium because it has an estimated sensitivity of 86% and
specificity of 92% after optimization for use in African buffalo [44]. For a few captures,
diagnosis was not possible if blood collection was incomplete or if errors in testing
resulted in unclear test results. Removal of these capture events resulted in the removal
of only six buffalo from our dataset (146 buffalo sampled).
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South Africa
Fig S8. Kruger National Park is on the northeastern boundary of South Africa. The
blown-up figure shows a google maps image of the park. Buffalo were initially captured
in the Lower Sabie (light yellow) Crocodile Bridge sections (dark yellow) of the park.
Red dots represent the re-capture locations for the subsequent capture. We account for
initial capture location in all statistical analyses although more detailed analyses of how
buffalo move over time and space are underway (7).
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